Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation (CONVINCE)
16 februari 2022 bijgewerkt door: Nicholas Hing Yee Liang, Clinical Research Centre, Malaysia
Effective Public Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation: A Randomized Controlled Experiment
This is a randomised controlled experiment in the form of a web based survey study which randomly exposes participants to different forms of public health messages, after which participants will be assessed on their intent to take up the COVID-19 vaccine, recommend the vaccine, and also willingness to propagate the exposed message.
Studie Overzicht
Toestand
Voltooid
Conditie
Interventie / Behandeling
Studietype
Ingrijpend
Inschrijving (Werkelijk)
5784
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
Selangor
-
Shah Alam, Selangor, Maleisië, 40170
- Institute for Clinical Research, National Institutes of Health, Malaysia
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
18 jaar en ouder (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Ja
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- Willing and able to give informed consent for participation in the trial
- Malaysian nationality.
- Can understand either the English or Malay language.
- Aged 18 years or above
Exclusion Criteria:
- Received at least one COVID-19 vaccination dose
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Descriptive Norm (70%)
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimenteel: Descriptive Norm
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimenteel: Healthcare worker (HCW) recommendation
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimenteel: Negative attribute framing
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimenteel: Positive attribute framing
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimenteel: Risky choice framing (Safety)
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimenteel: Risky choice framing (Side effects)
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimenteel: Control message
Control message containing only rally slogan: "It's safe and effective!"
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimenteel: Combination message: Descriptive Norm (70%) + Descriptive Norm
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimenteel: Combination message: Descriptive Norm (70%) + HCW recommendation
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimenteel: Combination message: Descriptive Norm (70%) + Negative attribute framing
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimenteel: Combination message: Descriptive Norm (70%) + Positive attribute framing
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimenteel: Combination message: Descriptive Norm (70%) + Risky choice framing (Safety)
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimenteel: Combination message: Descriptive Norm (70%) + Risky choice framing (Side effects)
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in intent to accept the COVID-19 vaccine amongst the Malaysian adult population.
Tijdsspanne: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 4 point ordinal scale.
Scale ranges from '"Definitely no", "Not sure, but probably no", "Not sure, but probably yes"to Definitely yes".
|
Immediately before and after message exposure during questionnaire administration.
|
|
Change in intent to recommend the COVID-19 vaccine to healthy adults.
Tijdsspanne: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately before and after message exposure during questionnaire administration.
|
|
Change in intent to recommend the COVID-19 vaccine to elderly.
Tijdsspanne: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately before and after message exposure during questionnaire administration.
|
|
Change in intent to recommend the COVID-19 vaccine to people with existing health conditions.
Tijdsspanne: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately before and after message exposure during questionnaire administration.
|
|
Intent to share message on social media platform.
Tijdsspanne: Immediately after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately after message exposure during questionnaire administration.
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Moderators of vaccination intent.
Tijdsspanne: Immediately after message exposure during questionnaire administration.
|
Outcome measure assessed using a series of questions answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately after message exposure during questionnaire administration.
|
|
Reliability of various information sources about COVID-19.
Tijdsspanne: Immediately after message exposure during questionnaire administration.
|
Outcome measure assessed using a questionnaire that list out various types of information sources and having participants to rate the reliability for each source using a 5 point ordinal scale.
Scale ranges from "Strongly not reliable", "Not reliable, "Not sure", "Reliable", and "Strongly reliable".
|
Immediately after message exposure during questionnaire administration.
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Yee Liang Hing, MSc., Clinical Research Centre, Malaysia
Publicaties en nuttige links
De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
29 april 2021
Primaire voltooiing (Werkelijk)
7 juni 2021
Studie voltooiing (Werkelijk)
7 juni 2021
Studieregistratiedata
Eerst ingediend
10 februari 2022
Eerst ingediend dat voldeed aan de QC-criteria
16 februari 2022
Eerst geplaatst (Werkelijk)
17 februari 2022
Updates van studierecords
Laatste update geplaatst (Werkelijk)
17 februari 2022
Laatste update ingediend die voldeed aan QC-criteria
16 februari 2022
Laatst geverifieerd
1 februari 2022
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- NMRR-21-26-58107
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
NEE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .